Publications

5898 Results

Development and Validation of a Gene Expression Signature to Predict Early Events in Patients with Follicular Lymphoma

Authors
C Ramsower;G Wright;H Li;J Cerhan;M Mauer;R Mwangi;A Rosenthal;A Novak;B Link;T Witzig;T Habermann;R Kridel;M LeBlanc;M Shadman;S Smith;J Friedberg;D Scott;C Steidl;L Staudt;L Rimsza
Journal / Conference
Blood Advances 2025 Dec 23;9(24):6443-6454. doi: 10.1182/bloodadvances.2025016827.
Year
2025
Research Committee(s)
Lymphoma
PMID
40966421
PMC
PMC12755980
Study Number(s)
S0016

Clinical Trial of Docetaxel with Androgen Receptor Pathway Inhibitors for Metastatic Castration-Sensitive Prostate Cancer Patients with a Suboptimal PSA Response

Authors
A Sokolova;M Ong;S Hotte;T Dorff;K Chi;A Wyatt;A Goldkorn;M Kolinsky;M Brundage;A Ndika;S Lerner;W Parulekar;K Ding;M Jafri
Journal / Conference
Prostate Cancer Foundation annual meeting (October 23-25, 2025, Carlsbad, CA)
Year
2025
Research Committee(s)
Genitourinary
Study Number(s)
CCTG-PR26

Breastfeeding after hormone-receptor positive breast cancer: results from the POSITIVE trial

Authors
F Peccatori
Journal / Conference
Journal of Clinical Oncology, 2025 Aug 20;43(24):2712-2719. doi: 10.1200/JCO-24-02697. Epub 2025 Jul 9.
Year
2025
Research Committee(s)
Cancer Survivorship
PMID
40632989
Study Number(s)
CTSU/A221405

Development and Validation of a Risk Prediction Model for Acute Care Use Among Older Patients with Advanced Cancer on Clinical Trials

Authors
D Hershman;C Till;M LeBlanc;S Ramsey;J Unger
Journal / Conference
JNCI-Journal of the National Cancer Institute djaf342; publ Dec 4, 2025; 10.1093/jnci/djaf342
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID41346251

Neoadjuvant PD-1 blockade in patients with surgically resectable desmoplastic 3 melanoma (SWOG S1512 cohort A)

Authors
K Kendra;S Bellasea;Z Eroglu;S Hu-Lieskovan;K Campbell;W Carson;D Wada;J Plaza;G In;A Ikeguchi;J Hyngstrom;A Brohl;B Chmielowski;N Khushalani;J Markowitz;M Monroe;C Contreras;E Medina;C Gonzalez;I Baselga Carretero;I Perez Garcilazo;A Vega-Crespo;J Ming Chen;N Naser Al Deen;S Patel;K Grossmann;V Sondak;E Sharon;J Moon;M Wu;A Ribas
Journal / Conference
Nature Cancer. 2026 Feb;7(2):272-282. doi: 10.1038/s43018-025-01113-y. Epub 2026 Jan 29.
Year
2025
Research Committee(s)
Melanoma
PMID
41611998
PMC
PMC12948668
Study Number(s)
S1512

Development and validation of a novel conditional event-free survival tool in diffuse large B-cell lymphoma

Authors
Z Chen;D Luan;R Rask;L Jakobsen;M Maurer;T El-Galaly;L Nastoupil;J Cerhan;C Flowers;B Link;I Lossos;D Stephens;J Cohen;J Habermann;G Nowakowski;N Bartlett;J Friedberg;B Kahl;J Leonard;P Brown;K Smedby;M Jerkeman;P Martin
Journal / Conference
Journal of Clinical Oncology
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1001

Clinical and molecular characterization of AXL in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world data

Authors
Ashouri K;Millstein J;Yang Y;Xiu J;Soni S;Mittal P;Algaze S;Torres-Gonzalez L;Jayachandran P;Zhang W;Mumenthaler S;Shields AF;Goldberg R;Lou E;Weinberg BA;Graeber TG;Marshall JL;Venook AP;Hoffmann A;Finley SD;Meyer AS;Battaglin F;Lenz HJ
Journal / Conference
Journal for ImmunoTherapy of Cancer. 2025 Dec 21; 13: e013186. DOI: 10.1136/jitc-2025-013186.
Year
2025
Research Committee(s)
Gastrointestinal
PMID
PMID41423272
Study Number(s)
CTSU/C80405

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201

Authors
Kam AE;Zhao F;Meropol NJ;Giantonio BJ;Diasio RB;Flynn PJ;Catalano P;Hartner L;Rowland KM;Song W;Mulcahy MF;Sinicrope FA;Whitehead RP;Mayer RJ;Petrelli N;O‘Dwyer PJ;Hamilton SR;Cella D;Benson AB
Journal / Conference
Oncologist. 2025 Dec 27; 31: oyaf416. DOI: 10.1093/oncolo/oyaf416.
Year
2025
Research Committee(s)
Gastrointestinal
PMID
PMID41397917
Study Number(s)
CTSU/E3201

Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial

Authors
Tripathi A;Chen Y;Jarrard DF;Garcia JA;Dreicer R;Liu G;Hussain MH;Shevrin DH;Cooney M;Eisenberger MA;Kohli M;Plimack ER;Vogelzang NJ;Picus J;Carducci MA;DiPaola RS;Sweeney CJ
Journal / Conference
Annals of Oncology. 2025 Nov 1; 36: 1409-1413. DOI: 10.1016/j.annonc.2025.08.004. Epub 2025 Aug 23
Year
2025
Research Committee(s)
Genitourinary

Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826

Authors
Rutherford SC;Li H;Herrera AF;LeBlanc ML;Ahmed S;Davison K;Parsons SK;Unger JM;Perry AM;Casulo C;Bartlett NL;Tuscano JM;Hess BT;Torka P;Kumar P;Jacobs R;Song JY;Castellino SM;Kahl B;Leonard JP;Smith SM;Friedberg JW;Evens AM
Journal / Conference
Journal of Clinical Oncology. 2025 Sep 20; 43: 2968-2973. DOI: 10.1200/JCO-25-00204.
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1826